Medical Care Technologies Inc. (OTC Pink:MDCE) Builds on Subsidiary Revenue Strength to Accelerate AI Health-Tech Mission in 2026
Rhea-AI Summary
Medical Care Technologies (OTC Pink: MDCE) announced on December 4, 2025 a strategic acceleration toward AI-driven health and wellness mobile applications.
The company says it will leverage two operating subsidiaries, Infinite Auctions (since 2016) and Real Game Used (since 2017), as stable revenue and brand pillars while shifting focus to build a catalog of AI apps for medical pre-screening, nutrition, wellness, and food intelligence. MDCE identified the first product as a food and recipe AI mobile app positioned in a multi-billion-dollar market and described this release as a foundation for broader consumer health AI offerings.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, MDCE declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
MDCE fell 16.67% while key peers were mixed: YUKA down 5.45%, BBTT up 1.52%, and others flat. No broad, aligned sector move is evident.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 09 | Shareholder update | Positive | -14.3% | Share structure stabilization and new tech partnership with AI tool updates. |
| Dec 08 | AI product update | Positive | +0.0% | Google-backed dermatology model integrated into melanoma and wound app. |
| Dec 05 | Capital structure | Positive | +40.0% | Reg A dilution period ends, enabling focus on launches and AI growth. |
| Dec 04 | AI strategy shift | Positive | +0.0% | Subsidiary strength used to fund AI apps in health and nutrition. |
| Dec 03 | Operating model | Positive | +0.0% | Lean outsourced AI model and pending patent reduce capital needs. |
Recent MDCE news has mostly seen price move in line with positive announcements, with one notable divergence on a partnership/update release that coincided with a selloff.
Over late November and early December 2025, MDCE reported closing its Reg A dilution phase, growing subsidiary revenue, and accelerating AI health-tech initiatives. AI releases have covered lean infrastructure, consumer pre-health screening, and a Google-backed dermatology and wound app. The December 4 announcement about leveraging Infinite Auctions and Real Game Used to fund AI apps fits this shift from financing to execution, using established businesses as pillars for new AI-driven consumer health tools.
Market Pulse Summary
This announcement highlighted MDCE’s plan to use Infinite Auctions and Real Game Used as long-term revenue and brand pillars while pushing into AI-driven mobile apps for pre-screening, nutrition, wellness, and food intelligence. In context of prior AI infrastructure and product updates, it marked a shift from groundwork to commercialization. Investors should watch progress on app launches, revenue traction relative to the $13.4 billion target market, and consistency of subsidiary revenue near $848,987 year-to-date.
Key Terms
artificial intelligence technical
AI-generated analysis. Not financial advice.
MESA, ARIZONA / ACCESS Newswire / December 4, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a strategic acceleration of its core mission in artificial intelligence-driven health and wellness technology. With Infinite Auctions (www.infiniteauctions.com) operating since 2016 and Real Game Used (www.realgameused.com) since 2017, both subsidiaries continue to provide brand strength, domain expertise, and emerging revenue that support MDCE's broader AI vision.
Leveraging the stability of these proven business units, MDCE is now shifting focus back to the parent company to build and launch a catalog of AI-based mobile applications centered on medical pre-screening, nutrition, wellness, and food intelligence - areas with significant global demand.
"Infinite Auctions and Real Game Used as long-term pillars will support our AI ambitions," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "Now we are accelerating into the next phase: scalable applications designed to enhance personal health and everyday decision-making worldwide."
MDCE's first release enters the high-growth food and recipe AI market - a multi-billion-dollar mobile app category that impacts nearly every adult globally. The company sees this product as the foundation for expanding into deeper consumer health improvements through AI.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (www.medicalcaretechnologies.com, www.mdcestock.com) develops AI-powered technology focused on consumer wellness, nutritional insight, and preventive screening. Supported by its established subsidiaries Infinite Auctions and Real Game Used, the Company is expanding its innovation pipeline to improve health outcomes through accessible artificial intelligence.
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those expressed due to risks and uncertainties.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC Pink:MDCE)
View the original press release on ACCESS Newswire
FAQ
What did Medical Care Technologies (MDCE) announce on December 4, 2025?
How will Infinite Auctions and Real Game Used support MDCE's AI plans (MDCE)?
What is MDCE's first AI product and what market does it target?
When did MDCE say its subsidiaries began operating?
What health areas will MDCE's AI apps focus on for MDCE shareholders?
Does the announcement include financial guidance or launch dates for MDCE's AI apps?
